News & Events


July 20, 2020

Precision BioLogic, a leading developer of hemostasis diagnostic products, is pleased to announce FDA 510(k) clearance and the launch of its new CRYOcheck Chromogenic Factor VIII assay in the U.S. This clearance follows authorizations received from regulatory authorities in Canada, the European Union, Australia, and New Zealand where the assay launched earlier this year.


Here’s a list of conferences we’ll be attending this year. If you’re planning on attending any of the same shows, be sure to swing by our booth for a chat because, after all, it’s you we want to see.

Oct 27 to 29
Virtual Meeting
Jul 12 to 14